Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


09th week of 2012 patent applcation highlights part 56
Patent application numberTitlePublished
20120053128Method of inhibiting angiogenesis2012-03-01
20120053129TARGET-ACTIVATED CELL/TISSUE-PENETRATING PEPTIDE FOR DELIVERY OF IMPERMEABLE COMPOUNDS AND USE THEREOF2012-03-01
20120053130COMPOSITION FOR ENHANCING ABSORPTION OF A DRUG AND METHOD2012-03-01
20120053131METHODS OF PREDICTING MEDICALLY REFRACTIVE ULCERATIVE COLITIS (MR-UC) REQUIRING COLECTOMY2012-03-01
20120053132COMPOSITIONS AND METHODS FOR INHIBITING CYTOCHROME P4502012-03-01
20120053133ANTISEPTIC AGENT COMPOSITION2012-03-01
20120053134PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEURONAL DAMAGE AND NEUROLOGICAL DISEASES2012-03-01
20120053135Drug composition for treating chronic liver disease and its application2012-03-01
20120053136DIAGNOSIS AND TREATMENT OF DRUG-RESISTANT EWING`S SARCOMA2012-03-01
20120053137Method for Treating Addiction Using Quercetin-Containing Compositions2012-03-01
20120053138FORMULATION OF A MIXTURE OF FREE-B-RING FLAVONOIDS AND FLAVANS FOR USE IN THE PREVENTION AND TREATMENT OF COGNITIVE DECLINE AND AGE-RELATED MEMORY IMPAIRMENTS2012-03-01
20120053139METHOD FOR IMPROVING PHARMACOKINETICS OF PROTEASE INHIBITORS AND PROTEASE INHIBITOR PRECURSORS2012-03-01
20120053140ADMINISTRATION OF AVERMECTIN/MILBEMYCIN COMPOUNDS FOR THE TREATMENT OF OPHTHALMIC PATHOLOGIES2012-03-01
20120053141Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis2012-03-01
20120053142COMPOSITIONS AND METHODS FOR MINIMIZING AND/OR REDUCING THE APPEARANCE OF DEFECTS AROUND EYES2012-03-01
20120053143TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT2012-03-01
20120053144Cobalamin Taxane Bioconjugates For Treating Eye Disease2012-03-01
20120053145ARIPIPRAZOLE COMPLEX FORMULATION AND METHOD2012-03-01
20120053146PESTICIDAL COMPOSITIONS2012-03-01
20120053147THIAZOLOPYRIMIDINONE DERIVATIVES AS PI3 KINASE INHIBITORS2012-03-01
20120053148INHIBITORS OF HEPATITIS C VIRUS2012-03-01
20120053149THIAZOLE DERIVATIVES AND THEIR USE AS P2Y12 RECEPTOR ANTAGONISTS2012-03-01
20120053150N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INIHIBITORS2012-03-01
20120053151DIMETHOATE LOW VOC FORMULATIONS2012-03-01
20120053152(R)-(-)-1,2-propanediol compositions and methods2012-03-01
20120053153TOPICAL GEL FORMULATION COMPRISING ORGANOPHOSPHATE INSECTICIDE AND PREPARATION THEREOF2012-03-01
20120053154COMPOSITION AND METHOD FOR INHIBITING BIOGENIC SULFIDE GENERATION2012-03-01
20120053155SYSTEM AND METHOD FOR REVERTING ANTIBIOTIC TOLERANCE OF BACTERIAL PERSISTER CELLS2012-03-01
20120053156COMPOSITIONS AND METHODS FOR LOOP DIURETICS WITH CONSISTENT BIOAVAILABILITY2012-03-01
20120053157METHODS FOR THE TREATMENT OR PROPHYLAXIS OF THROMBOSIS OR EMBOLISM2012-03-01
20120053158PREPARATION OF AN ACETYL SALICYLIC ACID/GLUTAMIC ACID COMPLEX FOR ORAL ADMINISTRATION2012-03-01
20120053159ISOTOPOLOGUES OF LENALIDOMIDE2012-03-01
20120053160Dosage Form for Hormonal Contraception2012-03-01
20120053161TOPICAL SOLUTION FORMULATIONS CONTAINING A CORTICOSTEROID AND A CYCLODEXTRIN2012-03-01
20120053162CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS2012-03-01
20120053163Steroids as Agonists for FXR2012-03-01
20120053164CYCLIC PYRIMIDIN-4-CARBOXAMIDES AS CCR2 RECEPTOR ANTAGONISTS FOR TREATMENT OF INFLAMMATION, ASTHMA AND COPD2012-03-01
20120053165Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators2012-03-01
201200531664-Oxadiazol-2-YL-Indazoles as Inhibitors of P13 Kinases2012-03-01
20120053167Triazine Derivatives as Kinase Inhibitors2012-03-01
20120053168FUSED BENZOAZEPINES AS NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS2012-03-01
20120053169COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF PSEUDOBULBAR AFFECT, NEUROLOGICAL DISEASES, INTRACTABLE AND CHRONIC PAIN AND BRAIN INJURY2012-03-01
20120053170NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF AS ANTICANCER DRUGS2012-03-01
20120053171Nitrogen-Containing Fused Heterocyclic Compounds and Their use as Beta Amyloid Production Inhibitors2012-03-01
20120053172USE OF A COMBINATION OF DIAZOXIDE AND METFORMIN FOR TREATING OBESITY OR OBESITY RELATED DISORDERS2012-03-01
20120053173HETEROCYCLIC COMPOUND2012-03-01
20120053174QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF2012-03-01
20120053175MLK INHIBITORS AND METHODS OF USE2012-03-01
20120053176ADENOSINE A3 RECEPTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF2012-03-01
20120053177COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR2012-03-01
201200531783-(1,2,3-Triazol-4-yl) pyrrolo [2,3-b] pyridine derivatives2012-03-01
20120053179Rho-Kinase Inhibitors2012-03-01
20120053180CYCLOHEXANE ANALOGUES AS GPR119 AGONISTS2012-03-01
20120053181PYRROLIDINE-DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS2012-03-01
20120053182METHODS OF ALLEVIATING OR TREATING SIGNS AND/OR SYMPTOMS ASSOCIATED WITH MODERATE TO SEVERE PARKINSON'S DISEASE2012-03-01
20120053183PIPERAZINYLPYRIMIDINE ANALOGUES AS PROTEIN KINASE INHIBITORS2012-03-01
20120053184SALTS OF 3-(1H-IND0L-3-YL)-4-[2-(4-METHYL-PIPERAZIN-I-YL)-QUINAZOLIN-4-YL]- -PYRROLE-2, 5-DI ONE2012-03-01
20120053185METHOD TO TREAT MELANOMA IN BRAF INHIBITOR-RESISTANT SUBJECTS2012-03-01
201200531862-(3-AMINOARYL) AMINO-4-ARYL-THIAZOLES AND THEIR USE AS C-KIT INHIBITORS2012-03-01
20120053187TRI-CYCLIC PYRAZOLOPYRIDINE KINASE INHIBITORS2012-03-01
20120053188COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF HYDROXAMIC ACID DERIVATIVES2012-03-01
20120053189BTK INHIBITORS FOR THE TREATMENT OF IMMUNE MEDIATED CONDITIONS2012-03-01
20120053190ORGANIC COMPOUNDS2012-03-01
20120053191OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS2012-03-01
20120053192Heterocyclic Substituted Acardite Derivate and Application Thereof2012-03-01
20120053193OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF2012-03-01
20120053194OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF2012-03-01
20120053195HYDROBROMIDE SALTS OF A PYRAZOLYLAMINOQUINAZOLINE2012-03-01
20120053196Combination Treatment of Breast Cancer2012-03-01
20120053197TRICYCLIC PYRIDINE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION2012-03-01
20120053198WATER-SOLUBLE SOLID PHARMACEUTICAL INCLUSION COMPLEXES AND THEIR AQUEOUS SOLUTIONS FOR ORAL, OPHTHALMIC, TOPICAL OR PARENTERAL USE CONTAINING A MACROLIDE AND CERTAIN CYCLODEXTRINS2012-03-01
20120053199NOSCAPINE AND ANALOGS AND METHODS RELATED THERETO2012-03-01
20120053200BACE 2 INHIBITORS2012-03-01
20120053201SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF2012-03-01
20120053202POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF2012-03-01
20120053203Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators2012-03-01
20120053204Substituted quinoline-3-carboxamides as KCNQ2/3 modulators2012-03-01
20120053205Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators2012-03-01
20120053206Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as KCNQ2/3 modulators2012-03-01
20120053207ANTIPSYCHOTIC TREATMENT BASED ON DRD2 OR ANKK1 SNP GENOTYPE2012-03-01
20120053208Curcumin Analogs as Dual JAK2/STAT3 Inhibitors and Methods of Making and Using the Same2012-03-01
20120053209ANTICANCER COMPOUNDS, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF2012-03-01
20120053210COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM2012-03-01
20120053211TREATMENT OF PANCREATIC CANCER2012-03-01
20120053212METHODS OF TREATING HUMANS UNDERGOING INJECTION OF A CONTRAST AGENT2012-03-01
201200532132-(4-SUBSTITUTED PHENYLAMINO) POLYSUBSTITUTED PYRIDINE COMPOUNDS AS INHIBITORS OF NON-NUCLEOSIDE HIV REVERSE TRANSCRIPTASE, PREPARATION METHODS AND USES THEREOF2012-03-01
20120053214THE LITTLE MOLECULE COMPOUND WHICH USED FOR PROMOTING THE STEM CELLS HYPERPLASIA AND THE USE THEREOF2012-03-01
20120053215ISOTHIAZOLONE-CONTAINING PRESERVATIVE WITH IMPROVED EFFECTIVENESS2012-03-01
20120053216PESTICIDAL COMPOSITIONS2012-03-01
20120053217COMPOSITION FOR PREPARING EMULSION OR MICROEMULSION FORMULATIONS2012-03-01
20120053218TRIAZOLE DERIVATIVES AS VASOPRESSIN-RECEPTOR INHIBITORS FOR TREATING CARDIAC INSUFFICIENCY2012-03-01
20120053219PROCESSES OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS2012-03-01
20120053220NOVEL LIPOXYGENASE INHIBITORS AS NEUROPROTECTIVE AGENTS2012-03-01
20120053221Polymers for Increasing the Soil Mobility of Low-Solubility Insecticides2012-03-01
20120053222Novel Metabolic Disease Therapy2012-03-01
20120053223COMPOSITIONS AND METHODS FOR TREATING RETROVIRUS INFECTIONS2012-03-01
20120053224COMPOSITIONS AND METHODS FOR MICRO-RNA EXPRESSION PROFILING OF CANCER STEM CELLS2012-03-01
20120053225AKT TYROSINE 176 PHOSPHORYLATION CANCER BIOMARKER2012-03-01
20120053226DESIGN OF OLIGONUCLEOTIDE ANALOGS AS THERAPEUTIC AGENTS2012-03-01
20120053227miR-33 INHIBITORS AND USES THEREOF2012-03-01
Website © 2025 Advameg, Inc.